|
Biologics studies show improvement for moderate to severe psoriasis March 18, 2004
Oral form of Tazorac shows efficacy and safety March 18, 2004
FDA approves Enbrel for treatment of moderate to severe plaque psoriasis May 3, 2004
Progress on Oregon Health Plan coverage for psoriasis May 11, 2004
FDA committee votes against oral retinoid recommendation July 13, 2004
FDA decision on oral retinoid Sept. 29, 2004
Enbrel prefilled syringes now available Oct. 15, 2004
Flu vaccines warranted for psoriasis patients Oct. 20, 2004
World Psoriasis Day 2004 Oct. 29, 2004
FDA accepts Remicade application for treatment of psoriatic arthritis Dec. 6, 2004
Injectable methotrexate shortage may last into the new year Dec. 17, 2004
Stat3 protein may be involved in psoriasis development Dec. 22, 2004
FDA, EMEA accept Humira application for treatment of psoriatic arthritis Dec. 22, 2004
| 
